Asclepii

Asclepii is a Cleveland-based biotechnology startup focused on regenerative medicine and advanced wound care. The company aims to revolutionize the treatment of chronic and acute wounds, such as diabetic foot ulcers, by developing cost-disruptive, scalable, and accessible therapies that reduce the need for expensive traditional interventions. Their product portfolio includes 'Poseidon,' an FDA-cleared nanosilver hydrogel wound dressing, and 'Artemis,' an innovative extracellular matrix (ECM) scaffold designed to promote tissue growth and reduce scarring. By leveraging nanotechnology and bioactive materials, Asclepii seeks to improve patient outcomes while significantly lowering treatment costs.